Corinnova

company

About

Corinnova is commercializing a breakthrough technological platform for the treatment of congestive heart failure.

  • 1 - 10

Details

Last Funding Type
Grant
Last Funding Money Raised
$0.99M
Industries
Health Care,Medical Device,Therapeutics
Founded date
Jan 1, 2004
Number Of Employee
1 - 10
Operating Status
Active

CorInnova Incorporated provides device-based therapies for the treatment of congestive heart failure. CorInnova’s non-blood-contacting soft robotic cardiac assist device could potentially triple or quadruple the number of heart failure patients who could be eligible for such a life-saving device therapy.”

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
$1.21M
Corinnova has raised a total of $1.21M in funding over 2 rounds. Their latest funding was raised on Nov 30, 2021 from a Grant round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Nov 30, 2021 Grant $0.99M 1 National Science Foundation Detail
Jan 31, 2019 Grant $225K 1 National Science Foundation Detail

Investors

Number of Lead Investors
Number of Investors
2
1
Corinnova is funded by 1 investors. National Science Foundation are the most recent investors.
Investor Name Lead Investor Funding Round
National Science Foundation Yes Grant